|
Sign In to gain access to subscriptions and/or personal tools.
|
Toxicology and Industrial Health, Vol. 15, No. 1-2,
48-64 (1999)
DOI: 10.1177/074823379901500106
Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat
Joseph Ostby
Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina
Emily Monosson
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina, Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, Monosson Environmental Research, Montagne, USA
William R. Kelce
Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, Monsanto Company, St. Louis, Missouri, USA
L. Earl Gray, Jr.
Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, gray.earl{at}epamail.epa.gov
In humans and rodents, exposure to antiandrogenic chemicals during sexual differentiation can produce malformations of the reproductive tract. Perinatal administration of 100 or 200 mg vinclozolin (V) kg–1 day–1 during sexual differentiation in rats induces female-like anogenital distance (AGD), retained nipples, cleft phallus with hypospadias, suprainguinal ectopic scrota/testes, a vaginal pouch, epididymal granulomas, and small to absent sex accessory glands in male offspring. Vinclozolin is metabolized to at least two active forms, M1 and M2, that display antiandrogenic activity by binding the androgen receptor (AR). Here, we present information on the reproductive effects of oral treatment with low dosage levels of V during sexual differentiation of the male rat. Vinclozolin was administered to the dam at 0, 3.125, 6.25, 12.5, 25, 50, or 100 mg kg–1 day–1 from gestational day 14 to postnatal day 3 (the period of fetal/neonatal testicular testosterone synthesis and sexual differentiation). At doses of 3.125 mg V kg–1 and above, AGD was significantly reduced in newborn male offspring and the incidence of areolas was increased. These effects were associated with permanent alterations in other androgen-dependent tissues. Ventral prostate weight in one year old male offspring was reduced in all treatment groups (significant at 6.25, 25, 50, and 100 mg kg–1 day–1), and permanent nipples were detected in males at 3.125 (1.4%), 6.25 (3.6%), 12.5 (3.9%), 25 (8.5%), 50 (91%), and 100 (100%) mg V kg–1 day–1. To date, permanent nipples have not been observed in a control male from any study in our laboratory. Vinclozolin treatment at 50 and 100 mg kg–1 day–1 induced reproductive tract malformations and reduced ejaculated sperm numbers and fertility. Even though all of the effects of V likely result from the same initial event (AR binding), the different endpoints displayed a wide variety of dose-response curves and ED50's. The dose-response data for several of the functional endpoints failed to display an obvious threshold. These data demonstrate that V produces subtle alterations in sexual differentiation of the external genitalia, ventral prostate, and nipple tissue in male rat offspring at dosage levels below the previously described no-observed-effect-level (NOEL). These effects occur at a dosage level an order of magnitude below that required to induce malformations and reduce fertility. Hence, multigenerational reproduction studies of antiandrogenic chemicals that were not conducted under the Environmental Protection Agency's new Harmonized Multigenerational Test Guidelines, which include endpoints sensitive to antiandrogens at low dosage levels, could yield a NOEL that is at least an order of magnitude too high.
Key Words: abnormal sexual differentiation • dose-response • hypospadias • risk assessment • vinclozolin
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. K. Hotchkiss, C. V. Rider, C. R. Blystone, V. S. Wilson, P. C. Hartig, G. T. Ankley, P. M. Foster, C. L. Gray, and L. E. Gray
Fifteen Years after "Wingspread"--Environmental Endocrine Disrupters and Human and Wildlife Health: Where We are Today and Where We Need to Go
Toxicol. Sci.,
October 1, 2008;
105(2):
235 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-H. Wang and L. S. Baskin
Endocrine Disruptors, Genital Development, and Hypospadias
J Androl,
September 1, 2008;
29(5):
499 - 505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease
Reproduction,
May 1, 2008;
135(5):
713 - 721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. W. Gaido, J. B. Hensley, D. Liu, D. G. Wallace, S. Borghoff, K. J. Johnson, S. J. Hall, and K. Boekelheide
Fetal Mouse Phthalate Exposure Shows that Gonocyte Multinucleation is Not Associated with Decreased Testicular Testosterone
Toxicol. Sci.,
June 1, 2007;
97(2):
491 - 503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C A Wilson and D C Davies
The control of sexual differentiation of the reproductive system and brain
Reproduction,
February 1, 2007;
133(2):
331 - 359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Anway, C. Leathers, and M. K. Skinner
Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease
Endocrinology,
December 1, 2006;
147(12):
5515 - 5523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Bisenius, D.N. R. Veeramachaneni, G. E. Sammonds, and S. Tobet
Sex Differences and the Development of the Rabbit Brain: Effects of Vinclozolin
Biol Reprod,
September 1, 2006;
75(3):
469 - 476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. F. M. Mikkila, J. Toppari, and J. Paranko
Effects of Neonatal Exposure to 4-Tert-Octylphenol, Diethylstilbestrol, and Flutamide on Steroidogenesis in Infantile Rat Testis
Toxicol. Sci.,
June 1, 2006;
91(2):
456 - 466.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Liu, K. P. Lehmann, M. Sar, S. S. Young, and K. W. Gaido
Gene Expression Profiling Following In Utero Exposure to Phthalate Esters Reveals New Gene Targets in the Etiology of Testicular Dysgenesis
Biol Reprod,
July 1, 2005;
73(1):
180 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vinggaard, S. Christiansen, P. Laier, M. E. Poulsen, V. Breinholt, K. Jarfelt, H. Jacobsen, M. Dalgaard, C. Nellemann, and U. Hass
Perinatal Exposure to the Fungicide Prochloraz Feminizes the Male Rat Offspring
Toxicol. Sci.,
June 1, 2005;
85(2):
886 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Noriega, J. Ostby, C. Lambright, V. S. Wilson, and L. E. Gray Jr.
Late Gestational Exposure to the Fungicide Prochloraz Delays the Onset of Parturition and Causes Reproductive Malformations in Male but Not Female Rat Offspring
Biol Reprod,
June 1, 2005;
72(6):
1324 - 1335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kitamura, T. Suzuki, S. Sanoh, R. Kohta, N. Jinno, K. Sugihara, S. Yoshihara, N. Fujimoto, H. Watanabe, and S. Ohta
Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds
Toxicol. Sci.,
April 1, 2005;
84(2):
249 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. M. M. Schreurs, E. Sonneveld, J. H. J. Jansen, W. Seinen, and B. van der Burg
Interaction of Polycyclic Musks and UV Filters with the Estrogen Receptor (ER), Androgen Receptor (AR), and Progesterone Receptor (PR) in Reporter Gene Bioassays
Toxicol. Sci.,
February 1, 2005;
83(2):
264 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Wolf, G. A. LeBlanc, and L. E. Gray Jr.
Interactive Effects of Vinclozolin and Testosterone Propionate on Pregnancy and Sexual Differentiation of the Male and Female SD Rat
Toxicol. Sci.,
March 1, 2004;
78(1):
135 - 143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster
Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat
Toxicol. Sci.,
August 1, 2003;
74(2):
393 - 406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nellemann, M. Dalgaard, H. R. Lam, and A. M. Vinggaard
The Combined Effects of Vinclozolin and Procymidone Do Not Deviate from Expected Additivity in Vitro and in Vivo
Toxicol. Sci.,
February 1, 2003;
71(2):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Y. Euling, C. Gennings, E. M. Wilson, J. A. Kemppainen, W. R. Kelce, and C. A. Kimmel
Response-Surface Modeling of the Effect of 5{alpha}-Dihydrotestosterone and Androgen Receptor Levels on the Response to the Androgen Antagonist Vinclozolin
Toxicol. Sci.,
October 1, 2002;
69(2):
332 - 343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vinggaard, C. Nellemann, M. Dalgaard, E. B. Jorgensen, and H. R. Andersen
Antiandrogenic Effects in Vitro and in Vivo of the Fungicide Prochloraz
Toxicol. Sci.,
October 1, 2002;
69(2):
344 - 353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Turner, N. J. Barlow, M. F. Struve, D. G. Wallace, K. W. Gaido, D. C. Dorman, and P. M. D. Foster
Effects of in Utero Exposure to the Organophosphate Insecticide Fenitrothion on Androgen-Dependent Reproductive Development in the Crl:CD(SD)BR Rat
Toxicol. Sci.,
July 1, 2002;
68(1):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Wolf, A. Hotchkiss, J. S. Ostby, G. A. LeBlanc, and L. E. Gray Jr.
Effects of Prenatal Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response Study
Toxicol. Sci.,
January 1, 2002;
65(1):
71 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Marty, J. W. Crissman, and E. W. Carney
Evaluation of the Male Pubertal Onset Assay to Detect Testosterone and Steroid Biosynthesis Inhibitors in CD Rats
Toxicol. Sci.,
April 1, 2001;
60(2):
285 - 295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tamura, S. C. Maness, K. Reischmann, D. C. Dorman, L. E. Gray, and K. W. Gaido
Androgen Receptor Antagonism by the Organophosphate Insecticide Fenitrothion
Toxicol. Sci.,
March 1, 2001;
60(1):
56 - 62.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Gray Jr., J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni, and L. Parks
Perinatal Exposure to the Phthalates DEHP, BBP, and DINP, but Not DEP, DMP, or DOTP, Alters Sexual Differentiation of the Male Rat
Toxicol. Sci.,
December 1, 2000;
58(2):
350 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Solomon and T. Schettler
Environment and health: 6. Endocrine disruption and potential human health implications
Can. Med. Assoc. J.,
November 1, 2000;
163(11):
1471 - 1476.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lambright, J. Ostby, K. Bobseine, V. Wilson, A. K. Hotchkiss, P. C. Mann, and L. E. Gray Jr.
Cellular and Molecular Mechanisms of Action of Linuron: An Antiandrogenic Herbicide that Produces Reproductive Malformations in Male Rats
Toxicol. Sci.,
August 1, 2000;
56(2):
389 - 399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Mylchreest, D. G. Wallace, R. C. Cattley, and P. M. D. Foster
Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-butyl) Phthalate during Late Gestation
Toxicol. Sci.,
May 1, 2000;
55(1):
143 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Wolf, G. A. LeBlanc, J. S. Ostby, and L. E. Gray Jr.
Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin
Toxicol. Sci.,
May 1, 2000;
55(1):
152 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
